Endospanin 1 (Endo1), a protein encoded in humans by the same gene than the leptin receptor (ObR), and increased by diet-induced obesity, is an important regulator of ObR trafficking and cell surface exposure, determining leptin signaling strength. Defective intracellular trafficking of the leptin receptor to the neuronal plasma membrane has been proposed as a mechanism underlying the development of leptin resistance observed in human obesity. More recently, Endo1 has emerged as a mediator of “selective leptin resistance.” The underlying mechanisms of the latter are not completely understood, but the possibility of differential activation of leptin signaling pathways was suggested among others. In this respect, the expression level of Endo1 is crucial for the appropriate balance between different leptin signaling pathways and leptin functions in the hypothalamus and is likely participating in selective leptin resistance for the control of energy and glucose homeostasis.

1.
Afshin
A
,
Forouzanfar
MH
,
Reitsma
MB
,
Sur
P
,
Estep
K
,
Lee
A
, et al.;
GBD 2015 Obesity Collaborators
.
Health Effects of Overweight and Obesity in 195 Countries over 25 Years
.
N Engl J Med
.
2017
Jul
;
377
(
1
):
13
27
.
[PubMed]
0028-4793
2.
Zhang
Y
,
Proenca
R
,
Maffei
M
,
Barone
M
,
Leopold
L
,
Friedman
JM
.
Positional cloning of the mouse obese gene and its human homologue
.
Nature
.
1994
Dec
;
372
(
6505
):
425
32
.
[PubMed]
0028-0836
3.
Farooqi
IS
,
Jebb
SA
,
Langmack
G
,
Lawrence
E
,
Cheetham
CH
,
Prentice
AM
, et al.
Effects of recombinant leptin therapy in a child with congenital leptin deficiency
.
N Engl J Med
.
1999
Sep
;
341
(
12
):
879
84
.
[PubMed]
0028-4793
4.
Pelleymounter
MA
, et al.
Effects of the obese Gene product on body weight regulation in ob/ob mice
,” Science,
1995
. [Online]. Available: http://www.sciencemag.org.gate2.inist.fr/content/269/5223/540.long. [Accessed: 08-Jul-2014].
5.
Ramachandrappa
S
,
Farooqi
IS
.
Genetic approaches to understanding human obesity
.
J Clin Invest
.
2011
Jun
;
121
(
6
):
2080
6
.
[PubMed]
0021-9738
6.
Considine
RV
,
Sinha
MK
,
Heiman
ML
,
Kriauciunas
A
,
Stephens
TW
,
Nyce
MR
, et al.
Serum immunoreactive-leptin concentrations in normal-weight and obese humans
.
N Engl J Med
.
1996
Feb
;
334
(
5
):
292
5
.
[PubMed]
0028-4793
7.
Mercer
JG
,
Hoggard
N
,
Williams
LM
,
Lawrence
CB
,
Hannah
LT
,
Trayhurn
P
.
Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization
.
FEBS Lett
.
1996
Jun
;
387
(
2-3
):
113
6
.
[PubMed]
0014-5793
8.
Balland
E
,
Dam
J
,
Langlet
F
,
Caron
E
,
Steculorum
S
,
Messina
A
, et al.
Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain
.
Cell Metab
.
2014
Feb
;
19
(
2
):
293
301
.
[PubMed]
1550-4131
9.
Cheung
CC
,
Clifton
DK
,
Steiner
RA
.
Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus
.
Endocrinology
.
1997
Oct
;
138
(
10
):
4489
92
.
[PubMed]
0013-7227
10.
Baskin
DG
,
Breininger
JF
,
Schwartz
MW
.
Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus
.
Diabetes
.
1999
Apr
;
48
(
4
):
828
33
.
[PubMed]
0012-1797
11.
Betley
JN
,
Cao
ZF
,
Ritola
KD
,
Sternson
SM
.
Parallel, redundant circuit organization for homeostatic control of feeding behavior
.
Cell
.
2013
Dec
;
155
(
6
):
1337
50
.
[PubMed]
0092-8674
12.
Schwartz
MW
,
Woods
SC
,
Porte
D
 Jr
,
Seeley
RJ
,
Baskin
DG
.
Central nervous system control of food intake
.
Nature
.
2000
Apr
;
404
(
6778
):
661
71
.
[PubMed]
0028-0836
13.
Scott
MM
,
Lachey
JL
,
Sternson
SM
,
Lee
CE
,
Elias
CF
,
Friedman
JM
, et al.
Leptin targets in the mouse brain
.
J Comp Neurol
.
2009
Jun
;
514
(
5
):
518
32
.
[PubMed]
0021-9967
14.
Meek
TH
,
Matsen
ME
,
Dorfman
MD
,
Guyenet
SJ
,
Damian
V
,
Nguyen
HT
, et al.
Leptin action in the ventromedial hypothalamic nucleus is sufficient, but not necessary, to normalize diabetic hyperglycemia
.
Endocrinology
.
2013
Sep
;
154
(
9
):
3067
76
.
[PubMed]
0013-7227
15.
Enriori
PJ
,
Sinnayah
P
,
Simonds
SE
,
Garcia Rudaz
C
,
Cowley
MA
.
Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance
.
J Neurosci
.
2011
Aug
;
31
(
34
):
12189
97
.
[PubMed]
0270-6474
16.
Ghamari-Langroudi
M
,
Srisai
D
,
Cone
RD
.
Multinodal regulation of the arcuate/paraventricular nucleus circuit by leptin
.
Proc Natl Acad Sci USA
.
2011
Jan
;
108
(
1
):
355
60
.
[PubMed]
0027-8424
17.
Bagnasco
M
,
Dube
MG
,
Katz
A
,
Kalra
PS
,
Kalra
SP
.
Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin
.
Obes Res
.
2003
Dec
;
11
(
12
):
1463
70
.
[PubMed]
1071-7323
18.
Leshan
RL
,
Björnholm
M
,
Münzberg
H
,
Myers
MG
 Jr
.
Leptin receptor signaling and action in the central nervous system
.
Obesity (Silver Spring)
.
2006
Aug
;
14
Suppl 5
:
208S
12S
.
[PubMed]
1930-7381
19.
Elmquist
JK
,
Bjørbaek
C
,
Ahima
RS
,
Flier
JS
,
Saper
CB
.
Distributions of leptin receptor mRNA isoforms in the rat brain
.
J Comp Neurol
.
1998
Jun
;
395
(
4
):
535
47
.
[PubMed]
0021-9967
20.
Grill
HJ
,
Schwartz
MW
,
Kaplan
JM
,
Foxhall
JS
,
Breininger
J
,
Baskin
DG
.
Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake
.
Endocrinology
.
2002
Jan
;
143
(
1
):
239
46
.
[PubMed]
0013-7227
21.
Hayes
MR
,
Skibicka
KP
,
Leichner
TM
,
Guarnieri
DJ
,
DiLeone
RJ
,
Bence
KK
, et al.
Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation
.
Cell Metab
.
2010
Jan
;
11
(
1
):
77
83
.
[PubMed]
1550-4131
22.
Hommel
JD
,
Trinko
R
,
Sears
RM
,
Georgescu
D
,
Liu
ZW
,
Gao
XB
, et al.
Leptin receptor signaling in midbrain dopamine neurons regulates feeding
.
Neuron
.
2006
Sep
;
51
(
6
):
801
10
.
[PubMed]
0896-6273
23.
Matheny
M
,
Strehler
KY
,
King
M
,
Tümer
N
,
Scarpace
PJ
.
Targeted leptin receptor blockade: role of ventral tegmental area and nucleus of the solitary tract leptin receptors in body weight homeostasis
.
J Endocrinol
.
2014
Jul
;
222
(
1
):
27
41
.
[PubMed]
0022-0795
24.
Kim
JG
,
Suyama
S
,
Koch
M
,
Jin
S
,
Argente-Arizon
P
,
Argente
J
, et al.
Leptin signaling in astrocytes regulates hypothalamic neuronal circuits and feeding
.
Nat Neurosci
.
2014
Jul
;
17
(
7
):
908
10
.
[PubMed]
1097-6256
25.
Djogo
T
,
Robins
SC
,
Schneider
S
,
Kryzskaya
D
,
Liu
X
,
Mingay
A
, et al.
Adult NG2-Glia Are Required for Median Eminence-Mediated Leptin Sensing and Body Weight Control
.
Cell Metab
.
2016
May
;
23
(
5
):
797
810
.
[PubMed]
1550-4131
26.
Couturier
C
,
Jockers
R
.
Activation of the leptin receptor by a ligand-induced conformational change of constitutive receptor dimers
.
J Biol Chem
.
2003
Jul
;
278
(
29
):
26604
11
.
[PubMed]
0021-9258
27.
Biener
E
,
Charlier
M
,
Ramanujan
VK
,
Daniel
N
,
Eisenberg
A
,
Bjørbaek
C
, et al.
Quantitative FRET imaging of leptin receptor oligomerization kinetics in single cells
.
Biol Cell
.
2005
Dec
;
97
(
12
):
905
19
.
[PubMed]
0248-4900
28.
Bates
SH
,
Stearns
WH
,
Dundon
TA
,
Schubert
M
,
Tso
AW
,
Wang
Y
, et al.
STAT3 signalling is required for leptin regulation of energy balance but not reproduction
.
Nature
.
2003
Feb
;
421
(
6925
):
856
9
.
[PubMed]
0028-0836
29.
Bates
SH
,
Dundon
TA
,
Seifert
M
,
Carlson
M
,
Maratos-Flier
E
,
Myers
MG
 Jr
.
LRb-STAT3 signaling is required for the neuroendocrine regulation of energy expenditure by leptin
.
Diabetes
.
2004
Dec
;
53
(
12
):
3067
73
.
[PubMed]
0012-1797
30.
Bates
SH
,
Kulkarni
RN
,
Seifert
M
,
Myers
MG
 Jr
.
Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis
.
Cell Metab
.
2005
Mar
;
1
(
3
):
169
78
.
[PubMed]
1550-4131
31.
Duan
C
,
Li
M
,
Rui
L
.
SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin
.
J Biol Chem
.
2004
Oct
;
279
(
42
):
43684
91
.
[PubMed]
0021-9258
32.
Morton
GJ
,
Gelling
RW
,
Niswender
KD
,
Morrison
CD
,
Rhodes
CJ
,
Schwartz
MW
.
Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons
.
Cell Metab
.
2005
Dec
;
2
(
6
):
411
20
.
[PubMed]
1550-4131
33.
Roman
EA
,
Reis
D
,
Romanatto
T
,
Maimoni
D
,
Ferreira
EA
,
Santos
GA
, et al.
Central leptin action improves skeletal muscle AKT, AMPK, and PGC1 alpha activation by hypothalamic PI3K-dependent mechanism
.
Mol Cell Endocrinol
.
2010
Jan
;
314
(
1
):
62
9
.
[PubMed]
0303-7207
34.
Rahmouni
K
,
Sigmund
CD
,
Haynes
WG
,
Mark
AL
.
Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin
.
Diabetes
.
2009
Mar
;
58
(
3
):
536
42
.
[PubMed]
0012-1797
35.
Minokoshi
Y
,
Alquier
T
,
Furukawa
N
,
Kim
YB
,
Lee
A
,
Xue
B
, et al.
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
.
Nature
.
2004
Apr
;
428
(
6982
):
569
74
.
[PubMed]
0028-0836
36.
Tanida
M
,
Yamamoto
N
,
Shibamoto
T
,
Rahmouni
K
.
Involvement of hypothalamic AMP-activated protein kinase in leptin-induced sympathetic nerve activation
.
PLoS One
.
2013
;
8
(
2
):
e56660
.
[PubMed]
1932-6203
37.
Bjorbak
C
,
Lavery
HJ
,
Bates
SH
,
Olson
RK
,
Davis
SM
,
Flier
JS
, et al.
SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985
.
J Biol Chem
.
2000
Dec
;
275
(
51
):
40649
57
.
[PubMed]
0021-9258
38.
Zabolotny
JM
,
Bence-Hanulec
KK
,
Stricker-Krongrad
A
,
Haj
F
,
Wang
Y
,
Minokoshi
Y
, et al.
PTP1B regulates leptin signal transduction in vivo
.
Dev Cell
.
2002
Apr
;
2
(
4
):
489
95
.
[PubMed]
1534-5807
39.
Loh
K
,
Fukushima
A
,
Zhang
X
,
Galic
S
,
Briggs
D
,
Enriori
PJ
, et al.
Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance
.
Cell Metab
.
2011
Nov
;
14
(
5
):
684
99
.
[PubMed]
1550-4131
40.
Bouret
SG
,
Bates
SH
,
Chen
S
,
Myers
MG
 Jr
,
Simerly
RB
.
Distinct roles for specific leptin receptor signals in the development of hypothalamic feeding circuits
.
J Neurosci
.
2012
Jan
;
32
(
4
):
1244
52
.
[PubMed]
0270-6474
41.
Rankinen
T
,
Zuberi
A
,
Chagnon
YC
,
Weisnagel
SJ
,
Argyropoulos
G
,
Walts
B
, et al.
The human obesity gene map: the 2005 update
.
Obesity (Silver Spring)
.
2006
Apr
;
14
(
4
):
529
644
.
[PubMed]
1930-7381
42.
Maffei
M
,
Halaas
J
,
Ravussin
E
,
Pratley
RE
,
Lee
GH
,
Zhang
Y
, et al.
Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
.
Nat Med
.
1995
Nov
;
1
(
11
):
1155
61
.
[PubMed]
1078-8956
43.
Ottaway
N
,
Mahbod
P
,
Rivero
B
,
Norman
LA
,
Gertler
A
,
D’Alessio
DA
, et al.
Diet-induced obese mice retain endogenous leptin action
.
Cell Metab
.
2015
Jun
;
21
(
6
):
877
82
.
[PubMed]
1550-4131
44.
Halaas
JL
,
Boozer
C
,
Blair-West
J
,
Fidahusein
N
,
Denton
DA
,
Friedman
JM
.
Physiological response to long-term peripheral and central leptin infusion in lean and obese mice
.
Proc Natl Acad Sci USA
.
1997
Aug
;
94
(
16
):
8878
83
.
[PubMed]
0027-8424
45.
Myers
MG
,
Cowley
MA
,
Münzberg
H
.
Mechanisms of leptin action and leptin resistance
.
Annu Rev Physiol
.
2008
;
70
(
1
):
537
56
.
[PubMed]
0066-4278
46.
Roujeau
C
,
Jockers
R
,
Dam
J
.
New pharmacological perspectives for the leptin receptor in the treatment of obesity
.
Front Endocrinol (Lausanne)
.
2014
Oct
;
5
:
167
.
[PubMed]
1664-2392
47.
Banks
WA
,
DiPalma
CR
,
Farrell
CL
.
Impaired transport of leptin across the blood-brain barrier in obesity
.
Peptides
.
1999
Nov
;
20
(
11
):
1341
5
.
[PubMed]
0196-9781
48.
Caro
JF
,
Kolaczynski
JW
,
Nyce
MR
,
Ohannesian
JP
,
Opentanova
I
,
Goldman
WH
, et al.
Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance
.
Lancet
.
1996
Jul
;
348
(
9021
):
159
61
.
[PubMed]
0140-6736
49.
Schwartz
MW
,
Peskind
E
,
Raskind
M
,
Boyko
EJ
,
Porte
D
 Jr
.
Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans
.
Nat Med
.
1996
May
;
2
(
5
):
589
93
.
[PubMed]
1078-8956
50.
Enriori
PJ
,
Evans
AE
,
Sinnayah
P
,
Jobst
EE
,
Tonelli-Lemos
L
,
Billes
SK
, et al.
Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons
.
Cell Metab
.
2007
Mar
;
5
(
3
):
181
94
.
[PubMed]
1550-4131
51.
Münzberg
H
,
Flier
JS
,
Bjørbaek
C
.
Region-specific leptin resistance within the hypothalamus of diet-induced obese mice
.
Endocrinology
.
2004
Nov
;
145
(
11
):
4880
9
.
[PubMed]
0013-7227
52.
Zhang
X
,
Zhang
G
,
Zhang
H
,
Karin
M
,
Bai
H
,
Cai
D
.
Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity
.
Cell
.
2008
Oct
;
135
(
1
):
61
73
.
[PubMed]
0092-8674
53.
Horvath
TL
,
Sarman
B
,
García-Cáceres
C
,
Enriori
PJ
,
Sotonyi
P
,
Shanabrough
M
, et al.
Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity
.
Proc Natl Acad Sci USA
.
2010
Aug
;
107
(
33
):
14875
80
.
[PubMed]
0027-8424
54.
Ozcan
L
,
Ergin
AS
,
Lu
A
,
Chung
J
,
Sarkar
S
,
Nie
D
, et al.
Endoplasmic reticulum stress plays a central role in development of leptin resistance
.
Cell Metab
.
2009
Jan
;
9
(
1
):
35
51
.
[PubMed]
1550-4131
55.
Diano
S
,
Kalra
SP
,
Horvath
TL
.
Leptin receptor immunoreactivity is associated with the Golgi apparatus of hypothalamic neurons and glial cells
.
J Neuroendocrinol
.
1998
Sep
;
10
(
9
):
647
50
.
[PubMed]
0953-8194
56.
Couturier
C
,
Sarkis
C
,
Séron
K
,
Belouzard
S
,
Chen
P
,
Lenain
A
, et al.
Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity
.
Proc Natl Acad Sci USA
.
2007
Dec
;
104
(
49
):
19476
81
.
[PubMed]
0027-8424
57.
Belouzard
S
,
Delcroix
D
,
Rouillé
Y
.
Low levels of expression of leptin receptor at the cell surface result from constitutive endocytosis and intracellular retention in the biosynthetic pathway
.
J Biol Chem
.
2004
Jul
;
279
(
27
):
28499
508
.
[PubMed]
0021-9258
58.
Vauthier
V
,
Derviaux
C
,
Douayry
N
,
Roux
T
,
Trinquet
E
,
Jockers
R
, et al.
Design and validation of a homogeneous time-resolved fluorescence-based leptin receptor binding assay
.
Anal Biochem
.
2013
May
;
436
(
1
):
1
9
.
[PubMed]
0003-2697
59.
Bailleul
B
,
Akerblom
I
,
Strosberg
AD
.
The leptin receptor promoter controls expression of a second distinct protein
.
Nucleic Acids Res
.
1997
Jul
;
25
(
14
):
2752
8
.
[PubMed]
0305-1048
60.
Vauthier
V
,
Jaillard
S
,
Journel
H
,
Dubourg
C
,
Jockers
R
,
Dam
J
.
Homozygous deletion of an 80 kb region comprising part of DNAJC6 and LEPR genes on chromosome 1P31.3 is associated with early onset obesity, mental retardation and epilepsy
.
Mol Genet Metab
.
2012
Jul
;
106
(
3
):
345
50
.
[PubMed]
1096-7192
61.
Séron
K
,
Couturier
C
,
Belouzard
S
,
Bacart
J
,
Monté
D
,
Corset
L
, et al.
Endospanins regulate a postinternalization step of the leptin receptor endocytic pathway
.
J Biol Chem
.
2011
May
;
286
(
20
):
17968
81
.
[PubMed]
0021-9258
62.
Vauthier
V
,
Swartz
TD
,
Chen
P
,
Roujeau
C
,
Pagnon
M
,
Mallet
J
, et al.
Endospanin 1 silencing in the hypothalamic arcuate nucleus contributes to sustained weight loss of high fat diet obese mice
.
Gene Ther
.
2014
Jul
;
21
(
7
):
638
44
.
[PubMed]
0969-7128
63.
Forsythe
E
,
Beales
PL
.
Bardet-Biedl syndrome
.
Eur J Hum Genet
.
2013
Jan
;
21
(
1
):
8
13
.
[PubMed]
1018-4813
64.
Han
YM
,
Kang
GM
,
Byun
K
,
Ko
HW
,
Kim
J
,
Shin
MS
, et al.
Leptin-promoted cilia assembly is critical for normal energy balance
.
J Clin Invest
.
2014
May
;
124
(
5
):
2193
7
.
[PubMed]
0021-9738
65.
Osório
J
.
Metabolism. Cilia length—role in energy balance
.
Nat Rev Endocrinol
.
2014
Jun
;
10
(
6
):
313
. 1759-5029
66.
Guo
DF
,
Cui
H
,
Zhang
Q
,
Morgan
DA
,
Thedens
DR
,
Nishimura
D
, et al.
The BBSome Controls Energy Homeostasis by Mediating the Transport of the Leptin Receptor to the Plasma Membrane
.
PLoS Genet
.
2016
Feb
;
12
(
2
):
e1005890
.
[PubMed]
1553-7390
67.
Seo
S
,
Guo
DF
,
Bugge
K
,
Morgan
DA
,
Rahmouni
K
,
Sheffield
VC
.
Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling
.
Hum Mol Genet
.
2009
Apr
;
18
(
7
):
1323
31
.
[PubMed]
0964-6906
68.
J.
Wauman
,
L.
De Ceuninck
,
N.
Vanderroost
,
S.
Lievens
, and
J.
Tavernier
, “
RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding.
,” J. Cell Sci., vol. 124, no. Pt 6, pp. 921–32, Mar.
2011
.
69.
L.
De Ceuninck
,
J.
Wauman
,
D.
Masschaele
,
F.
Peelman
, and
J.
Tavernier
, “
Reciprocal cross-regulation between RNF41 and USP8 controls cytokine receptor sorting and processing.
,” J. Cell Sci., vol. 126, no. Pt 16, pp. 3770–81, Aug.
2013
.
70.
Wijesuriya
TM
,
De Ceuninck
L
,
Masschaele
D
,
Sanderson
MR
,
Carias
KV
,
Tavernier
J
, et al.
The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways
.
Hum Mol Genet
.
2017
Nov
;
26
(
21
):
4215
30
.
[PubMed]
0964-6906
71.
Pravdivyi
I
,
Ballanyi
K
,
Colmers
WF
,
Wevrick
R
.
Progressive postnatal decline in leptin sensitivity of arcuate hypothalamic neurons in the Magel2-null mouse model of Prader-Willi syndrome
.
Hum Mol Genet
.
2015
Aug
;
24
(
15
):
4276
83
.
[PubMed]
0964-6906
72.
R.
Mazor
, et al.
, “
Cleavage of the leptin receptor by matrix metalloproteinase–2 promotes leptin resistance and obesity in mice
,” Sci. Transl. Med., vol. 10, no. 455, p. eaah6324, Aug.
2018
.
73.
Miksztowicz
V
,
Siseles
N
,
Fernandez Machulsky
N
,
Schreier
L
,
Berg
G
.
Increase in MMP-2 activity in overweight and obese women is associated with menopausal status
.
Climacteric
.
2012
Dec
;
15
(
6
):
602
6
.
[PubMed]
1369-7137
74.
Miksztowicz
V
,
Muzzio
ML
,
Royer
M
,
Prada
M
,
Wikinski
R
,
Schreier
L
, et al.
Increased plasma activity of metalloproteinase 2 in women with metabolic syndrome
.
Metabolism
.
2008
Nov
;
57
(
11
):
1493
6
.
[PubMed]
0026-0495
75.
H.
Huang
,
W.
Wang
, and
Y.-X.
Tao
, “
Pharmacological chaperones for the misfolded melanocortin-4 receptor associated with human obesity.
,” Biochim. Biophys. Acta, vol. 1863, no. 10 Pt A, pp. 2496–2507, Oct.
2017
.
76.
Kim
TH
,
Choi
DH
,
Vauthier
V
,
Dam
J
,
Li
X
,
Nam
YJ
, et al.
Anti-obesity phenotypic screening looking to increase OBR cell surface expression
.
J Biomol Screen
.
2014
Jan
;
19
(
1
):
88
99
.
[PubMed]
1087-0571
77.
Vauthier
V
,
Roujeau
C
,
Chen
P
,
Sarkis
C
,
Migrenne
S
,
Hosoi
T
, et al.
Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling
.
Mol Metab
.
2016
Nov
;
6
(
1
):
159
72
.
[PubMed]
2212-8778
78.
Pan
WW
,
Myers
MG
 Jr
.
Leptin and the maintenance of elevated body weight
.
Nat Rev Neurosci
.
2018
Feb
;
19
(
2
):
95
105
.
[PubMed]
1471-003X
79.
De Souza
CT
,
Araujo
EP
,
Bordin
S
,
Ashimine
R
,
Zollner
RL
,
Boschero
AC
, et al.
Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus
.
Endocrinology
.
2005
Oct
;
146
(
10
):
4192
9
.
[PubMed]
0013-7227
80.
Milanski
M
,
Degasperi
G
,
Coope
A
,
Morari
J
,
Denis
R
,
Cintra
DE
, et al.
Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity
.
J Neurosci
.
2009
Jan
;
29
(
2
):
359
70
.
[PubMed]
0270-6474
81.
Girotti
M
,
Donegan
JJ
,
Morilak
DA
.
Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress
.
Psychoneuroendocrinology
.
2013
Jul
;
38
(
7
):
1158
69
.
[PubMed]
0306-4530
82.
Timper
K
,
Denson
JL
,
Steculorum
SM
,
Heilinger
C
,
Engström-Ruud
L
,
Wunderlich
CM
, et al.
IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling
.
Cell Reports
.
2017
Apr
;
19
(
2
):
267
80
.
[PubMed]
2211-1247
83.
Morgan
DA
,
Thedens
DR
,
Weiss
R
,
Rahmouni
K
.
Mechanisms mediating renal sympathetic activation to leptin in obesity
.
Am J Physiol Regul Integr Comp Physiol
.
2008
Dec
;
295
(
6
):
R1730
6
.
[PubMed]
0363-6119
84.
Brown
MS
,
Goldstein
JL
.
Selective versus total insulin resistance: a pathogenic paradox
.
Cell Metab
.
2008
Feb
;
7
(
2
):
95
6
.
[PubMed]
1550-4131
85.
Otero
YF
,
Stafford
JM
,
McGuinness
OP
.
Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux
.
J Biol Chem
.
2014
Jul
;
289
(
30
):
20462
9
.
[PubMed]
0021-9258
86.
K.
Rahmouni
,
W. G.
Haynes
,
D. A.
Morgan
, and
A. L.
Mark
, “
Selective resistance to central neural administration of leptin in agouti obese mice.
,” Hypertension, vol. 39, no. 2 Pt 2, pp. 486–90, Feb.
2002
.
87.
Rahmouni
K
,
Morgan
DA
,
Morgan
GM
,
Mark
AL
,
Haynes
WG
.
Role of selective leptin resistance in diet-induced obesity hypertension
.
Diabetes
.
2005
Jul
;
54
(
7
):
2012
8
.
[PubMed]
0012-1797
88.
Correia
ML
,
Haynes
WG
,
Rahmouni
K
,
Morgan
DA
,
Sivitz
WI
,
Mark
AL
.
The concept of selective leptin resistance: evidence from agouti yellow obese mice
.
Diabetes
.
2002
Feb
;
51
(
2
):
439
42
.
[PubMed]
0012-1797
89.
Mark
AL
.
Selective leptin resistance revisited
.
Am J Physiol Regul Integr Comp Physiol
.
2013
Sep
;
305
(
6
):
R566
81
.
[PubMed]
0363-6119
90.
Faouzi
M
,
Leshan
R
,
Björnholm
M
,
Hennessey
T
,
Jones
J
,
Münzberg
H
.
Differential accessibility of circulating leptin to individual hypothalamic sites
.
Endocrinology
.
2007
Nov
;
148
(
11
):
5414
23
.
[PubMed]
0013-7227
91.
Harlan
SM
,
Guo
DF
,
Morgan
DA
,
Fernandes-Santos
C
,
Rahmouni
K
.
Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effects
.
Cell Metab
.
2013
Apr
;
17
(
4
):
599
606
.
[PubMed]
1550-4131
92.
Harlan
SM
,
Morgan
DA
,
Dellsperger
DJ
,
Myers
MG
 Jr
,
Mark
AL
,
Rahmouni
K
.
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor
.
Hypertension
.
2011
Mar
;
57
(
3
):
627
32
.
[PubMed]
0194-911X
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.